| Issue Date | Title | Author(s) |
| 2014-01-01 | Oral treatment with Cu<sup>II</sup>(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis | Roberts, BR; Lim, NKH; McAllum, EJ; Donnelly, PS; Hare, DJ; Doble, PA; Turner, BJ; Price, KA; Lim, SC; Paterson, BM; Hickey, JL; Rhoads, TW; Williams, JR; Kanninen, KM; Hung, LW; Liddell, JR; Grubman, A; Monty, JF; Llanos, RM; Kramer, DR; Mercer, JFB; Bush, AI; Masters, CL; Duce, JA; Li, QX; Beckman, JS; Barnham, KJ; White, AR; Crouch, PJ |
| 2017-07-01 | Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson’s disease brain | Trist, BG; Davies, KM; Cottam, V; Genoud, S; Ortega, R; Roudeau, S; Carmona, A; De Silva, K; Wasinger, V; Lewis, SJG; Sachdev, P; Smith, B; Troakes, C; Vance, C; Shaw, C; Al-Sarraj, S; Ball, HJ; Halliday, GM; Hare, DJ; Double, KL |
| 2016-04-01 | Efficacy of peptide nucleic acid and selected conjugates against specific cellular pathologies of amyotrophic lateral sclerosis. | Browne, EC; Parakh, S; Duncan, LF; Langford, SJ; Atkin, JD; Abbott, BM |
| 2022-09-14 | Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord. | Trist, BG; Genoud, S; Roudeau, S; Rookyard, A; Abdeen, A; Cottam, V; Hare, DJ; White, M; Altvater, J; Fifita, JA; Hogan, A; Grima, N; Blair, IP; Kysenius, K; Crouch, PJ; Carmona, A; Rufin, Y; Claverol, S; Van Malderen, S; Falkenberg, G; Paterson, DJ; Smith, B; Troakes, C; Vance, C; Shaw, CE; Al-Sarraj, S; Cordwell, S; Halliday, G; Ortega, R; Double, KL |
